A potential explanation for this phenomenon is that albumin infusion prevented the development of cardiovascular incidents in septic patients with CHD and thus reduced mortality but did not reverse the mortality relative to cardiovascular events once this process occurred. This evidence concerns the gene ALB and coronary artery disorder.